跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/CTRI/2011/12/002277
CTRI/2011/12/002277招募中2 期

Double blind, placebo controlled, randomized, controlled trial to evaluate the efficacy of adjuvant treatment with homeopathic medication thuja (arbor vitae) in decreasing severity and decreasing post-surgical recurrence in recurrent respiratory papillomatosis

Indian Council of Medical Research0 个研究点目标入组 40 人开始时间: 待定最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

试验速览

阶段
2 期
状态
招募中
入组人数
40
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •1. Papillomatous lesion of the respiratory tract.
  • •2. Primary as well as recurrent lesions shall be included.
  • •3. Informed consent of patient for study participation and for regular clinical review.

排除标准

  • •1. Pregnancy
  • •2. Breast feeding
  • •3. Hepatic or renal impairment as indicated by baseline biochemical testing.
  • •4. Use of alternate systemic or topical medications for respiratory Papillomatosis.
  • •5. Significant uncontrolled systemic illness.

研究者

相似试验

进行中（未招募）
不适用
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.
EUCTR2008-002264-34-LTETI Pharma GmbH210
进行中（未招募）
1 期
Randomised, double blinded, placebo controlled, parallel group study to evaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients with allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.
EUCTR2008-002264-34-PLETI Pharma GmbH210
进行中（未招募）
不适用
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.
EUCTR2008-002264-34-DEETI Pharma GmbH210
进行中（未招募）
不适用
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitisation against grass pollen AND birch pollen.MedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039095Term: Rhinitis seasonal
EUCTR2008-002264-34-BGETI Pharma GmbH210
进行中（未招募）
不适用
Clinical trial to evaluate the relapse prevention of a hypericum extract in patients with major depressioModerate depressive episodes
EUCTR2008-001417-26-DESteigerwald Arzneimittelwerk GmbH